The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Attending an industry event? We would love to connect. Search upcoming events using the drop-downs below to search by region or market category. You can also view our archived events here.
FilterClear all Results found
Market Category
Capability
Year
Month
Event
Event
BIO-Europe 2024
Visit booth #100 at BIO-Europe 2024 from November 4-6 in Stockholm, Sweden, to discover our CDMO and CRO services and solutions for large molecule drugs, including biologics.
Visit booth #80-81 at AusBiotech 2024 to learn how our end-to-end CDMO and CRO services and solutions can support your unique drug development and manufacturing journey.
Visit booth #B13 at ESGCT 2024 to explore our comprehensive CDMO services and solutions, including cold and ultra-cold supply chain management and logistics for advanced therapies.
Visit booth #1620 at AAPS 2024 PharmSci 360 from October 20-23 to discover how Thermo Fisher Scientific can help you know what’s ahead when it comes to oral solid dose product development and manufacturing.
Visit Thermo Fisher Scientific’s booth at GCSG 2024 from October 15-17, 2024, in Malta to discover our CDMO and CRO services and solutions designed to accelerate your clinical trials.
Meet with our CDMO experts at Meeting on the Mesa to discuss how our advanced therapy development and manufacturing services can support your program’s success.
12th Annual Outsourcing in Clinical Trials Nordics 2024
Meet with Thermo Fisher Scientific at the 12th Annual Outsourcing in Clinical Trials Nordics 2024 to discover our CDMO services and solutions, including comprehensive capabilities for clinical trials.
Connect with Thermo Fisher Scientific at ChemOutsourcing 2024 from September 3-6, 2024, to explore our CDMO capabilities for small molecule active pharmaceutical ingredients (APIs).